Meera Chand

24.4k citations

50 papers · 3.3k indexed · 2 hit papers · h-index 20

Impact in

Modeling and Simulation top 0.5%
- COVID-19 epidemiological studies
Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology

Papers in

Infectious Diseases 29
- SARS-CoV-2 and COVID-19 Research 13
- COVID-19 Clinical Research Studies 12
- SARS-CoV-2 detection and testing 7
Endocrinology 5
- Diphtheria, Corynebacterium, and Tetanus 4

Co-authors: Mary Ramsay Maria Zambon Richard Myers Kevin Brown Jamie Lopez Bernal Natalie Groves Julia Stowe Nick Andrews
Journals: Eurosurveillance (5 papers)Epidemiology and Infection (4 papers)Journal of Hospital Infection (4 papers)The Lancet Regional Health - Europe (2 papers)The Journal of Immunology (2 papers)
Partner nations: United Kingdom Netherlands Switzerland

In The Last Decade

Meera Chand

47 papers receiving 3.2k citations

Hit Papers

align trajectories log scale

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant 2021 · 1.7k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 New England Journal of Medicine
2012 Eurosurveillance

Peers

Countries citing papers authored by Meera Chand

Since Specialization

Citations

This map shows the geographic impact of Meera Chand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meera Chand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meera Chand more than expected).

Fields of papers citing papers by Meera Chand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meera Chand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meera Chand. The network helps show where Meera Chand may publish in the future.

Co-authors

The 25 scholars most cited alongside Meera Chand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Meera Chand Line = papers co-authored together Meera Chand links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Persistent elevation in incidence of pneumonia in children in England, 2023/24 Eurosurveillance ·Daniel Todkill, Theresa Lamagni, Richard Pebody, Mary Ramsay, Daisy Woolham, Alicia Demirjian, Antoine Salzmann, Meera Chand, Helen E. Hughes, Christopher Bennett, Russell Hope, Conall Watson, Colin Brown, Alex J. Elliot	2024	4
2	Towards the development of a SARS-CoV-2 variant risk assessment tool: expert consultation on the assessment of scientific evidence on emerging variants The Lancet Microbe ·Nathalie Worp, Lorenzo Subissi, Mark D. Perkins, Maria D. Van Kerkhove, Anurag Agrawal, Meera Chand, Janko van Beek, Bas B. Oude Munnink, Marion Koopmans	2023	1
3	Representativeness of whole-genome sequencing approaches in England: the importance for understanding inequalities associated with SARS-CoV-2 infection Epidemiology and Infection ·Katherine A. Twohig, Katie Harman, Asad Zaidi, Shirin Aliabadi, Sophie Nash, Mary Sinnathamby, Ian Harrison, Eileen Gallagher, Natalie Groves, Frank Schwach, Clare Pearson, Alicia Thornton, Richard Myers, Meera Chand, Simon Thelwall, Gavin Dabrera	2023	1
4	Vaccine effectiveness against hospitalisation estimated using a test-negative case-control study design, and comparative odds of hospital admission and severe outcomes with COVID-19 sub-lineages BQ.1, CH.1.1. and XBB.1.5 in England The Lancet Regional Health - Europe ·Freja Kirsebom, Katie Harman, Rachel Lunt, Nick Andrews, Natalie Groves, Nurin Abdul Aziz, Russell Hope, Julia Stowe, Meera Chand, Mary Ramsay, Gavin Dabrera, Meaghan Kall, Jamie Lopez Bernal	2023	15
5	Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID‐19 cases treated with sotrovimab in the community in England Influenza and Other Respiratory Viruses ·Katie Harman, Sophie Nash, Harriet Webster, Natalie Groves, Jo Hardstaff, Jessica R. E. Bridgen, Paula Blomquist, Russell Hope, Efejiro Ashano, Richard Myers, Sakib Rokadiya, Susan Hopkins, Colin Brown, Meera Chand, Gavin Dabrera, Simon Thelwall	2023	14
6	Responsive modelling of the mpox epidemic in England as a cross-government and academia collaboration: the process, challenges, and lessons learned The Lancet Microbe ·Jasmina Panovska‐Griffiths, Nicholas A. Watkins, Fergus Cumming, Luke Hounsome, André Charlett, Xu‐Sheng Zhang, Thomas Finnie, Thomas Ward, Meera Chand, Johanna Hutchinson	2023	6
7	Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages The Journal of Infectious Diseases ·Tommy Nyberg, Katie Harman, Asad Zaidi, Shaun R. Seaman, Nick Andrews, Sophie Nash, André Charlett, Jamie Lopez Bernal, Richard Myers, Natalie Groves, Eileen Gallagher, Saheer E. Gharbia, Meera Chand, Simon Thelwall, Daniela De Angelis, Gavin Dabrera, Anne M. Presanis	2022	6
8	Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England Nature Communications ·Harriet Webster, Tommy Nyberg, Mary Sinnathamby, Nurin Abdul Aziz, Neil M. Ferguson, Giulia Seghezzo, Paula Blomquist, Jessica R. E. Bridgen, Meera Chand, Natalie Groves, Richard Myers, Russell Hope, Efejiro Ashano, Jamie Lopez Bernal, Daniela De Angelis, Gavin Dabrera, Anne M. Presanis, Simon Thelwall	2022	18
9	Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England The Lancet Regional Health - Europe ·Freja Kirsebom, Nick Andrews, Julia Stowe, Natalie Groves, Meera Chand, Mary Ramsay, Jamie Lopez Bernal	2022	22
10	COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England The Lancet Infectious Diseases ·Freja Kirsebom, Nick Andrews, Julia Stowe, Samuel Toffa, Ruchira Sachdeva, Eileen Gallagher, Natalie Groves, Anne Marie O’Connell, Meera Chand, Mary Ramsay, Jamie Lopez Bernal	2022	106
11	Development and evaluation of a nanopore 16S rRNA gene sequencing service for same day targeted treatment of bacterial respiratory infection in the intensive care unit Journal of Infection ·Rossella Baldan, Penelope R. Cliff, Sarah S. Burns, A M Alvarez Medina, Graeme C. Smith, Rahul Batra, Alberto Cerda, Rebekah Wilson, Tammy Merrill, Shona J. Lewis, Amita Patel, Dakshika Jeyaratnam, Duncan Wyncoll, Nicholas Barrett, Meera Chand, Jonathan D. Edgeworth	2021	15
12	Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant New England Journal of Medicine ·Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, Eileen Gallagher, Ruth Simmons, Simon Thelwall, Julia Stowe, Elise Tessier, Natalie Groves, Gavin Dabrera, Richard Myers, Colin Campbell, Gayatri Amirthalingam, Matt Edmunds, Maria Zambon, Kevin Brown, Susan Hopkins, Meera Chand, Mary Ramsay Hit paper breakdown →	2021	1738
13	Genome analysis following a national increase in Scarlet Fever in England 2014 BMC Genomics ·(unknown), Victoria J. Chalker, Aleksey Jironkin, Juliana Coelho, Ali Al‐Shahib, Steve Platt, Georgia Kapatai, Roger Daniel, Chenchal Dhami, Marisa Laranjeira, Timothy E. Chambers, Rebecca Guy, Theresa Lamagni, Timothy G. Harrison, Meera Chand, Alan P. Johnson, Anthony Underwood	2017	47
14	Impact of changes in Clostridium difficile diagnostic testing on detection of C. difficile infection and all England mandatory surveillance data Journal of Hospital Infection ·Meera Chand, M. Fleming, S. Wellsteed, M.C. Kelsey	2011	8
15	Kinetics of Connective Tissue Growth Factor Expression during Experimental Proliferative Glomerulonephritis Journal of the American Society of Nephrology ·Yasuhiko Ito, Roel Goldschmeding, Richard J. Bende, Nike Claessen, Meera Chand, Livio Kleij, Ton J. Rabelink, Jan J. Weening, Jan Aten	2001	85
16	HgCl2 and IL4 differentially modify expression of major histocompatibility complex class II molecules RT1.B and RT1.D in B lymphocytes from Brown Norway and Lewis rats Transplantation Proceedings ·A. Roos, Esther J.M. Schilder-Tol, Meera Chand, Jan J. Weening, Jan Aten	1997	3
17	Thiol Levels in CD134-Defined Subsets of Rat T Lymphocytes: Possible Implications for HgCl2-Induced Immune Dysregulation Biochemical and Biophysical Research Communications ·Anja Roos, Nike Claessen, Esther J.M. Schilder-Tol, Meera Chand, Jan J. Weening, Jan Aten	1997	8
18	Expression of different metallothionein messenger ribonucleic acids in motor cortex, spinal cord and liver from patients with amyotrophic lateral sclerosis Journal of the Neurological Sciences ·Harriet G. T. Blaauwgeers, Meera Chand, Frank M. van den Berg, J.M.B.V. de Jong, Dirk Troost	1996	33
19	Functional properties of human B cell subpopulations defined by monoclonal antibodies HB4 and FMC7. The Journal of Immunology ·A C Bloem, Meera Chand, I. DOLLEKAMP, Ger T. Rijkers	1988	11
20	Mitogenic stimulation of malignant B cells CLL: Diminished in-vitro stimulation with anti-CR1 antibodies Leukemia Research ·Andries C. Bloem, Meera Chand, Mohamed R. Daha, Bert J. E. G. Bast, R. E. Ballieux	1988	1

About Meera Chand

Meera Chand is a scholar working on Infectious Diseases, Endocrinology, Clinical Biochemistry, Critical Care and Intensive Care Medicine and Applied Microbiology and Biotechnology, having authored 50 papers that have together received 3.3k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (12 papers), SARS-CoV-2 detection and testing (7 papers), Bacterial Identification and Susceptibility Testing (5 papers), Streptococcal Infections and Treatments (5 papers), Mycobacterium research and diagnosis (5 papers), T-cell and B-cell Immunology (4 papers) and Diphtheria, Corynebacterium, and Tetanus (4 papers). The work is most often cited by research in Modeling and Simulation (656 citations), Infectious Diseases (2.4k citations), Health (677 citations), Animal Science and Zoology (269 citations) and Epidemiology (449 citations). Meera Chand has collaborated with scholars based in United Kingdom, Netherlands and Switzerland. Frequent co-authors include Mary Ramsay, Maria Zambon, Richard Myers, Kevin Brown, Jamie Lopez Bernal, Natalie Groves, Julia Stowe, Nick Andrews, Eileen Gallagher and Susan Hopkins. Their work appears in journals such as Eurosurveillance, Epidemiology and Infection, Journal of Hospital Infection, The Lancet Regional Health - Europe and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact